FDA to Review Olanzapine-Samidorphan Combo (Again); Ketamine for PTSD?

(MedPage Today) — After an initial positive review from an advisory panel but subsequent FDA rejection in November 2020, the FDA accepted Alkermes’ resubmission of its new drug application for ALKS 3831, a combination olanzapine/samidorphan treatment…
Read More